Skip to main content

Study M504

Study name

Guida F 2018

Title

Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice

Overall design

The aim of this study was to examine the behavioural, biochemical and electrophysiological alterations, as well as gut microbiota composition in a model of antibiotic-induced experimental dysbiosis. C57BL/6 mice were treated with Ampicillin, Streptomycin and Clindamycin (ASC) in the drinking water (Dysbiotic group) or sterile water only (0-14 days) (control group). Afterwards, they were treated with probiotic or saline via gavage (14-21 days). N-acylserotonin, N-acylethanolamine and endocannabinoid levels in jejunum, ileum and duodenum were measured.

Study Type

Type1;

Type2;

Data available

Unavailable

Organism

Mouse; C57/BL6 mouse;

Categories of depression

Animal model; Other animal model; Other animal model;

Criteria for depression

Tail suspension test, forced swimming test

Sample size

40

Tissue

Peripheral; Gut; Ileum;

Peripheral; Gut; Duodenum;

Peripheral; Gut; Jejunum;

Platform

MS-based; LC-MS: LC20AB with hybrid detector IT-TOF (Shimadzu Corporation, Kyoto, Japan);

PMID

28890155

DOI

10.1016/j.bbi.2017.09.001

Citation

Guida F, Turco F, Iannotta M, et al. Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. Brain Behav Immun. 2018;67:230-45.

Metabolite

Anandamide;

Oleoylethanolamide;

Arachidonoyl Serotonin;

N-[2-(5-Hydroxy-1H-indol-3-YL)ethyl]octadec-9-enamide;